title: Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
authors.affiliation: Department of Surgery, University of Cambridge, Addenbrooke's Hospital, England.
authors.forename: P J
authors.initials: PJ
authors.lastname: Friend
authors.forename: H
authors.initials: H
authors.lastname: Waldmann
authors.forename: G
authors.initials: G
authors.lastname: Hale
authors.forename: S
authors.initials: S
authors.lastname: Cobbold
authors.forename: P
authors.initials: P
authors.lastname: Rebello
authors.forename: S
authors.initials: S
authors.lastname: Thiru
authors.forename: N V
authors.initials: NV
authors.lastname: Jamieson
authors.forename: P S
authors.initials: PS
authors.lastname: Johnston
authors.forename: R Y
authors.initials: RY
authors.lastname: Calne
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D015703:Antigens, CD / Q000627:therapeutic use*; D000951:Antigens, Neoplasm; D000074301:CD52 Antigen; D006023:Glycoproteins; D006084:Graft Rejection; D007165:Immunosuppression Therapy; D007262:Infusions, Intravenous; D016030:Kidney Transplantation / Q000276:immunology*; D016031:Liver Transplantation / Q000276:immunology*; D016853:Muromonab-CD3; D010865:Pilot Projects; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000951:Antigens, Neoplasm; D000074301:CD52 Antigen; D006023:Glycoproteins; D016853:Muromonab-CD3